gene fragments unique malignancies approach allow physicians profile invasive sampling says david hoon molecular oncologist john wayne cancer center institute santa monica California long term goal identify genetic guides point physicians tumor location patterns characteristic stage determine monitor treatment disease progression patients says brian durie oncologist cedars sinai medical center samuel oschin comprehensive cancer institute los angeles fleischhacker cautions preparing tests routine cancer screening likely years today sensitive techniques detect rare mutations healthy people clinical consequence successful application testing circulating dna date area prenatal care late 1990s researchers recognized fetal dna detected mother blood albeit low levels opening door noninvasive